Results 51 to 60 of about 114,860,682 (209)

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

Discrimination of invasive ductal and lobular carcinoma of the breast based on the combination of enhanced Legendre polynomial, kinetic features and deep learning features [PDF]

The fifth most common cause of cancer-related deaths among women worldwide is breast cancer, which is the most common cancer among women globally. Early detection of breast cancer through regular screenings and awareness of symptoms can lead to better ...
Al-Waely, N. K. N., Aljobouri, H. K., Rabha W. Ibrahim, R. W., Jalab, H. A., Hasan, A. M., Meziane, F.   +5 more
core   +1 more source

Application of MR Cytometry in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparative Study

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background MR cytometry imaging is developed to characterize in vivo microstructures. Its clinical value in predicting pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for breast cancer remains unknown. Purpose To implement MR cytometry to predict pCR for breast cancer and compare the performance of different ...
Jie Ding, Diwei Shi, Shiyun Sun, Jinlong Zheng, Wentao Yang, Caixia Fu, Dazhi Chen, Junzhong Xu, Hua Guo, Chao You, Yajia Gu   +10 more
wiley   +1 more source

Lobular carcinoma in situ of the breast – correlation between minimally invasive biopsy and final pathology

, 2016
Introduction : Lobular carcinoma in situ (LCIS) is regarded as a non-obligate precursor of invasive breast cancer (IBC). Hence, the optimal management of LCIS found on minimally invasive breast biopsy remains a subject of debate.
Agnieszka Hałoń, Rafał Matkowski, Piotr Kasprzak, Bartłomiej Szynglarewicz   +3 more
core   +1 more source

Primary neuroendocrine carcinoma of the breast: report of 2 cases and literature review

Radiology Case Reports, 2017
Neuroendocrine tumors of the breast are very rare accounting for less than 0.1% of all breast cancers and less than 1% of all neuroendocrine tumors.
Fernando Collado-Mesa, MD, Jose M. Net, MD, Geetika A. Klevos, MD, Monica M. Yepes, MD   +3 more
doaj   +1 more source

High-risk lesions of the breast: concurrent diagnostic tools and management recommendations

Insights into Imaging, 2021
Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are composed of a variety of pathologies with differing risks of associated malignancy. While open excision was previously preferred to manage all high-risk lesions,
Francesca Catanzariti, Daly Avendano, Giuseppe Cicero, Margarita Garza-Montemayor, Carmelo Sofia, Emmanuele Venanzi Rullo, Giorgio Ascenti, Katja Pinker-Domenig, Maria Adele Marino   +8 more
doaj   +1 more source

Comparison of Continuous‐Time Random Walk and Fractional Order Calculus Diffusion Models for Preoperative Breast Lesion Characterization: Diagnosis, Biomarker Prediction and Molecular Subtyping

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Accurate preoperative characterization of breast lesions is important for individualized management. The conventional monoexponential (Mono) model has limited ability to capture the complex microstructure of lesions. Non‐Gaussian diffusion models, including continuous‐time random walk (CTRW) and fractional‐order calculus (FROC), may
Yimeng Cao, Shaomin Li, Zhexuan Yang, Xueyan Liu, Shifang Tan, Tian Ren, Wenjia Wang, Haiyang Li, Xingzhi Chen, Xin Zhao, Meiying Cheng   +10 more
wiley   +1 more source

Atypical Lobular Hyperplasia and Lobular Carcinoma in Situ without other High-Risk Lesions Diagnosed on Vacuum-Assisted Core Needle Biopsy. The Problem of Excisional Biopsy

, 2009
ims Verification of clinical procedure in patients with primary diagnosis of lobular carcinoma in situ and atypical lobular hyperplasia found on the basis of 11-gauge mammotomic biopsy.
Anna Pawelska, Karol Polom, Pawel Murawa, Dawid Murawa   +3 more
core   +1 more source

Oncoplastic Surgery Versus Total Breast Reconstruction in Locally Advanced and Multicentric Carcinomas. A Matched Comparative Cohort Study of Oncologic and Aesthetic Outcomes

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background/Objective This study aimed to compare extreme oncoplastic surgery (EO‐partial breast reconstruction for tumors > 5 cm or multicentric lesions) with extreme reconstruction (ER‐mastectomy with reconstruction for tumors >5 cm or multicentric lesions).
Aline Regina Nunes‐Reis, Regis Resende Paulinelli, Rosemar Macedo Sousa Rahal, Luiz Fernando Jubé Ribeiro, Ruffo de Freitas Júnior   +4 more
wiley   +1 more source

The lobular neoplasia enigma: management and prognosis in a long follow-up case series

World Journal of Surgical Oncology, 2021
Background Many oncologists debate if lobular neoplasia (LN) is a risk factor or an obligatory precursor of more aggressive disease. This study has three aims: (i) describe the different treatment options (surgical resection vs observation), (ii ...
Jasna Metovic, Simona Osella Abate, Fulvio Borella, Elena Vissio, Luca Bertero, Giovanna Mariscotti, Manuela Durando, Rebecca Senetta, Ada Ala, Chiara Benedetto, Anna Sapino, Paola Cassoni, Isabella Castellano   +12 more
doaj   +1 more source